
    
      Study participants will receive a single dose of IMOVAX Polioâ„¢ vaccine at 2, 3, and 4 months
      of age, respectively. Each participant will make a total of 7 visits. Safety will be
      monitored at each visit and up to 30 days after each vaccination.
    
  